Fate Therapeutics

FATE Micro Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$1.22

-1.61% heute

52W: $0.68 – $1.94

52W Low: $0.68 Position: 42.9% 52W High: $1.94

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

21.34x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$141.8M

Marktkapitalisierung

Umsatzwachstum

-26.4%

YoY Umsatzwachstum

Gewinnmarge

—

Nettomarge

ROE

-51.84%

Eigenkapitalrendite

Beta

2.24

Marktsensitivität

Short Interest

9.13%

% der Aktien leerverkauft

Ø Volumen

1,636,370

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

None

9 Analysten

Ø Kursziel

$4.94

+305.28% Upside

Kursziel Spanne

$2.00 – $8.00

Über das Unternehmen

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated i

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 161 Börse: NGM

Trading-Daten

50-Day MA: $1.26

200-Day MA: $1.16

Volumen: 646,007

Ø Volumen: 1,636,370

Short Ratio: 5.42

Kurs/Buchwert: 0.68x

Verschuldung/EK: 37.58x

Free Cash Flow: $-51,558,500

Wo kann ich Fate Therapeutics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →